5fzm
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal structure of the catalytic domain of human JARID1B in complex with 3D fragment 5-(2-fluorophenyl)-1,3-oxazole-4-carboxylic acid (N09989b) (ligand modelled based on PANDDA event map, SGC - Diamond I04-1 fragment screening)== | |
| - | + | <StructureSection load='5fzm' size='340' side='right' caption='[[5fzm]], [[Resolution|resolution]] 2.49Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5fzm]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FZM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5FZM FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene>, <scene name='pdbligand=P60:5-(2-FLUOROPHENYL)-1,3-OXAZOLE-4-CARBOXYLIC+ACID'>P60</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |
| - | [[Category: | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5fyc|5fyc]], [[5fyh|5fyh]], [[5fyi|5fyi]], [[5fym|5fym]], [[5fys|5fys]], [[5fyt|5fyt]], [[5fyu|5fyu]], [[5fyv|5fyv]], [[5fyy|5fyy]], [[5fyz|5fyz]], [[5fz0|5fz0]], [[5fz1|5fz1]], [[5fz3|5fz3]], [[5fz4|5fz4]], [[5fz6|5fz6]], [[5fz7|5fz7]], [[5fz8|5fz8]], [[5fz9|5fz9]], [[5fza|5fza]], [[5fzb|5fzb]], [[5fzc|5fzc]], [[5fzd|5fzd]], [[5fze|5fze]], [[5fzf|5fzf]], [[5fzg|5fzg]], [[5fzh|5fzh]], [[5fzi|5fzi]], [[5fzk|5fzk]], [[5fzl|5fzl]], [[5fzo|5fzo]]</td></tr> |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5fzm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fzm OCA], [http://pdbe.org/5fzm PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fzm RCSB], [http://www.ebi.ac.uk/pdbsum/5fzm PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5fzm ProSAT]</span></td></tr> |
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/KDM5B_HUMAN KDM5B_HUMAN]] Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-9' or H3 'Lys-27'. Demethylates trimethylated, dimethylated and monomethylated H3 'Lys-4'. Acts as a transcriptional corepressor for FOXG1B and PAX9. Favors the proliferation of breast cancer cells by repressing tumor suppressor genes such as BRCA1 and HOXA5. In contrast, may act as a tumor suppressor for melanoma.<ref>PMID:12657635</ref> <ref>PMID:16645588</ref> <ref>PMID:17320161</ref> <ref>PMID:17363312</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Arrowsmith, C H]] | ||
| + | [[Category: Bountra, C]] | ||
| + | [[Category: Brennan, P E]] | ||
| + | [[Category: Burgess-Brown, N A]] | ||
[[Category: Collins, P]] | [[Category: Collins, P]] | ||
| - | [[Category: | + | [[Category: Delft, F Von]] |
| + | [[Category: Edwards, A M]] | ||
[[Category: Gileadi, C]] | [[Category: Gileadi, C]] | ||
| + | [[Category: Johansson, C]] | ||
| + | [[Category: Krojer, T]] | ||
| + | [[Category: Kupinska, K]] | ||
| + | [[Category: Nowak, R]] | ||
[[Category: Oppermann, U]] | [[Category: Oppermann, U]] | ||
| + | [[Category: Pearce, N]] | ||
| + | [[Category: Strain-Damerell, C]] | ||
[[Category: Szykowska, A]] | [[Category: Szykowska, A]] | ||
| - | [[Category: Burgess-Brown, N.A]] | ||
| - | [[Category: Von Delft, F]] | ||
| - | [[Category: Pearce, N]] | ||
| - | [[Category: Edwards, A.M]] | ||
[[Category: Talon, R]] | [[Category: Talon, R]] | ||
| - | [[Category: | + | [[Category: Diamond i04-1]] |
| - | [[Category: | + | [[Category: Fragment screening]] |
| - | [[Category: | + | [[Category: Jarid1b]] |
| - | [[Category: | + | [[Category: Oxidoreductase]] |
| - | [[Category: | + | [[Category: Pandda]] |
| - | [[Category: | + | [[Category: Plu1]] |
| + | [[Category: Sgc]] | ||
| + | [[Category: Structural genomic]] | ||
Revision as of 13:42, 29 March 2017
Crystal structure of the catalytic domain of human JARID1B in complex with 3D fragment 5-(2-fluorophenyl)-1,3-oxazole-4-carboxylic acid (N09989b) (ligand modelled based on PANDDA event map, SGC - Diamond I04-1 fragment screening)
| |||||||||||
Categories: Arrowsmith, C H | Bountra, C | Brennan, P E | Burgess-Brown, N A | Collins, P | Delft, F Von | Edwards, A M | Gileadi, C | Johansson, C | Krojer, T | Kupinska, K | Nowak, R | Oppermann, U | Pearce, N | Strain-Damerell, C | Szykowska, A | Talon, R | Diamond i04-1 | Fragment screening | Jarid1b | Oxidoreductase | Pandda | Plu1 | Sgc | Structural genomic
